Analystreport

Cellectis S.A. (NASDAQ: CLLS) had its "outperform" rating re-affirmed by analysts at Wells Fargo & Company. They now have a $40.00 price target on the stock, up previously from $33.00.

Cellectis S.A. - American Depositary Shares  (CLLS) 
Last cellectis s.a. - american depositary shares earnings: 3/4 04:30 pm Check Earnings Report
US:NASDAQ Investor Relations: cellectis.com/en/investors